The Latest in Multiple Sclerosis Hub

Neighborhood-level data sheds new light on racial and ethnic diversity in MS

April 11, 2022

Multiple Sclerosis

Keto diet in MS tied to less disability, better quality of life

April 5, 2022

Multiple Sclerosis

Early MS biomarkers may improve prediction of long-term outcomes

March 15, 2022

Multiple Sclerosis

B-cell depletion overkill?

March 14, 2022

Multiple Sclerosis

Home cognitive therapy looks feasible in MS

March 11, 2022

Multiple Sclerosis

DMTs tied to lower MS relapse during reproductive therapy

March 11, 2022

Multiple Sclerosis

MRI biomarker to be tested in MS

March 9, 2022

Multiple Sclerosis

Ozanimod shows long-term safety, despite a pandemic

March 4, 2022

Multiple Sclerosis

B-cell therapy for MS may impact COVID-19 vaccination

March 3, 2022

Evidence mounts for paramagnetic rim lesions in diagnosing MS

March 2, 2022

Multiple Sclerosis

Spinal cord atrophy predicts ‘silent progression’ in MS

March 2, 2022

Multiple Sclerosis

B-cell repletion is common with MS drug, but no symptom worsening

November 11, 2021

Multiple Sclerosis

Brief, automated cognitive test may offer key advantages in MS

November 10, 2021

Multiple Sclerosis

Specialty pharmacists may speed time to MS treatment

November 10, 2021

Multiple Sclerosis

Cannabis use common for MS-related spasticity

November 3, 2021

Multiple Sclerosis